Form 8-K - Current report:
SEC Accession No. 0001401708-23-000225
Filing Date
2023-10-10
Accepted
2023-10-10 06:02:01
Documents
14
Period of Report
2023-10-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nstg-20231006.htm   iXBRL 8-K 32407
2 EX-99.1 nstg-8kex991.htm EX-99.1 17744
6 nstg-logo.jpg GRAPHIC 29107
  Complete submission text file 0001401708-23-000225.txt   224052

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nstg-20231006.xsd EX-101.SCH 1948
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nstg-20231006_lab.xml EX-101.LAB 24139
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nstg-20231006_pre.xml EX-101.PRE 12550
8 EXTRACTED XBRL INSTANCE DOCUMENT nstg-20231006_htm.xml XML 2728
Mailing Address 530 FAIRVIEW AVENUE NORTH SEATTLE WA 98109
Business Address 530 FAIRVIEW AVENUE NORTH SEATTLE WA 98109 206-378-6266
NanoString Technologies Inc (Filer) CIK: 0001401708 (see all company filings)

EIN.: 200094687 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35980 | Film No.: 231315350
SIC: 2836 Biological Products, (No Diagnostic Substances)